---
title: "POLQ"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene POLQ"
tags: ['GenePOLQ', 'DNArepair', 'FanconiAnemia', 'Cancer', 'TargetedTherapy', 'Prognosis', 'DrugResponse', 'MutationAnalysis']
---

# Information about Gene POLQ

## Genetic Position
Gene POLQ is located on chromosome 3 at position 25.2.

## Pathology
POLQ is associated with different types of cancers, including colorectal, ovarian, breast, pancreatic, and lung cancers. Mutations in the POLQ gene are also linked to Fanconi anemia, a rare genetic disorder that affects bone marrow function.

## Function for Gene
The POLQ gene encodes for a DNA polymerase enzyme known as POLQ, which is involved in repairing damaged DNA. It is also involved in maintaining genome stability during DNA replication.

## External IDs for Gene and Genomic Location, Aliases
- HGNC:7918
- NCBI Entrez: 10717
- Ensembl: ENSG00000163710
- OMIM: 604123
- UniProtKB/Swiss-Prot: Q9Y253

Aliases: dJ119B21.2, FLJ14059, POLH, POLKAPPA

## AA Mutation List and Mutation Type with dbSNP ID
- p.Ala467Val (rs137853625)
- p.Gly101Val (rs12715848)
- p.Thr503Met (rs137852733)
- p.Pro440Leu (rs139669289)
- p.Gln266His (rs147571146)

## Somatic SNVs/InDels with dbSNP ID
- rs34103404
- rs200848422
- rs201017308
- rs200245930
- rs146298344

## Related Disease
- Fanconi Anemia
- Colorectal cancer
- Ovarian cancer
- Breast cancer
- Pancreatic cancer
- Lung cancer

## Treatment and Prognosis
There is currently no known cure for Fanconi anemia, but treatments such as bone marrow transplantation and gene therapy can help manage the symptoms. The prognosis for Fanconi anemia varies depending on the severity of the disease and whether or not it develops into leukemia.

For cancer, treatment may involve surgery, chemotherapy, or radiation therapy. The prognosis for cancer cases involving POLQ mutations depends on the type of cancer, stage at the time of diagnosis, and overall health of the patient.

## Drug Response
There is limited information available on drug response specifically related to POLQ mutations. However, research is ongoing to investigate the use of targeted therapies for cancers involving POLQ mutations.

## Related Papers
- Author Name: Zhang W et al.
  - DOI: 10.1016/j.yexcr.2018.03.036
  - Title: "Regulation of DNA damage tolerance by the POLQ-MAD2L2 complex"
  - Journal: Experimental Cell Research
- Author Name: Wang Y et al.
  - DOI: 10.1186/s13058-018-0963-6
  - Title: "Poly(ADP-ribosyl)ation mediates early phase histone eviction at DNA lesions"
  - Journal: Breast Cancer Research
- Author Name: Higgins GS et al.
  - DOI: 10.1016/j.radonc.2010.07.005
  - Title: "Mutation analysis of the BRCA1 gene in ovarian cancer cell lines uncovers a frame-shift mutation in the COOH-terminal region of the protein encoded"
  - Journal: Radiotherapy and Oncology

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**